Back

Learner’s Digest International (TM)

  • Colitis, Ulcerative
  • Crohn Disease
  • Inflammatory Bowel Diseases
  • Infliximab

Precision Medicine in Inflammatory Bowel Disease

The goal of this program is to improve use of precision medicine in inflammatory bowel disease (IBD). After hearing and assimilating this program, the clinician will be better able to:Optimize use of infliximab in ulcerative colitis.Differentiate among drug classes in effectiveness for treatment of significant colonic disease in Crohn disease.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    May 22, 2027 7 months left